Zebra Biologics Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
See more in Biomedtracker

Latest on Zebra Biologics Inc.

Scrip

AbbVie Expects 9% Tax Rate, Thanks To US Tax Reform Law

 
• By Joseph Haas

AbbVie Inc. was going to report solid fourth quarter and full-year 2017 business anyway, but its projection that US tax reform would give it an industry-best effective tax rate of 9% in 2018 astonis

In Vivo

Deals Shaping The Medical Industry, February 2017

 
• By Steven Muntner, Amanda Micklus, Beth Allan, Maureen Riordan, and Deanna Kamienski

IN VITRO DIAGNOSTICS Mergers & Acquisitions PerkinElmer Inc. Tulip Diagnostics Pvt. Ltd. PerkinElmer Inc. is acquiring Indian firm Tulip Diagnostics Pvt. Ltd. (Jan.) Tulip focuses on assay sys

Scrip

Deal Watch: More Predictions 2017 Will Be A Banner Year For Deal-Making

 
• By Joseph Haas and Ying Huang

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Jan. 9-24. Deal Watc

Scrip

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed

 
• By Deanna Kamienski

Biopharmaceutical start-ups brought in 19% less funding in the first quarter of 2017 as compared with the previous quarter, but venture capital investors placed big bets on a few new companies, includ